Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Boehringer Ingelheim starts enrolling participants in phase I study of BI-1323495

April 8, 2021

INSERM and others present monoclonal antibodies targeting IL-20RB

March 31, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Boision present antibodies binding TSLP

March 30, 2021

Phase IIb/III study of Zyesami for respiratory failure in critical COVID-19 meets primary endpoint

March 29, 2021

Foresee begins phase II/III study of FP-025 in COVID-19-associated ARDS

March 29, 2021

FDA accepts IND for phase Ib study of AT-100 for bronchopulmonary dysplasia

March 26, 2021

Sorrento reports further phase Ib data on COVI-MSC for COVID-19-induced ARDS

March 26, 2021

Vasomune provides preliminary phase I data for AV-001

March 26, 2021

Incyte reports phase III results with ruxolitinib for COVID-19-associated ARDS

March 19, 2021

PDE4 inhibitors divulged by Hubei Bio-Pharmaceutical, Humanwell Healthcare

March 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...